With earnings 20 days away, the high short ratio creates a potential squeeze setup. The bullish initiation from BMO, while conservative on price, adds to the positive chorus. Traders should watch for a beat-and-raise that could trigger a short-covering rally, but the insider sales warrant caution on position size.
How the stock moved after the report
BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jul 9 $327.11entry
- T+1 · 4mo ago +0.82%α +0.39% · $329.78
- T+5 · 4mo ago +1.25%α +1.38% · $331.20
- T+20 · 3mo ago +3.15%α +0.91% · $337.43
- T+60 · 7w ago −15.80%α −17.43% · $275.43
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BMO Capital initiated coverage on Stryker Corp (SYK) at Outperform with a $369 price target, representing 12.9% upside from the current $326.85. The firm’s 53% accuracy on 1,842 rated calls places it near the middle of the analyst pack, but the call aligns with a strongly bullish consensus. The Street is 77% Buy-rated (27 of 35 analysts), with a mean target of $386.60 and median of $385.00. Current price implies 18.3% upside to the mean, so BMO’s target is more conservative than the average. Momentum is positive: 1 upgrade, 0 downgrades in the past 30 days, and EPS revisions for the current fiscal year show a slight upward tilt (2 up, 1 down). Insider selling by an executive (Robert Fletcher, ~$1.3M on May 28) provides a mild contrarian signal, partially offset by a congressional buy in April. The next earnings report is due July 29, 2026, within 20 days, adding a near-term catalyst. The high short-interest ratio of 76.2% could amplify any post-earnings move. Bottom line: BMO’s initiation adds a new bullish voice, but its below-consensus target and recent insider sales warrant a measured approach.
Impact Score
Consensus & Targets
Of 35 analysts covering SYK, 13 are Strong Buy, 14 are Buy, and 8 are Hold, 77% Buy-rated. No Sell or Strong Sell ratings. The consensus is overwhelmingly bullish and has been directionally stable for months.
Mean PT is $386.60, median $385.00, high $465.00, low $315.00. Current price of $326.85 implies 18.3% upside to the mean. BMO’s $369 target sits 4.5% below the mean and 4.2% below the median, making it one of the more conservative bullish calls.
Recent Analyst Activity
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-07-09 | BMO Capital | initiate | Outperform | $369.00 |
| 2026-07-06 | Evercore ISI Group | maintain | Outperform | No target |
| 2026-06-05 | Leerink Partners | maintain | Outperform | $407.00 |
| 2026-05-04 | Truist Securities | reiterate | Hold | $330.00 |
| 2026-05-04 | Barclays | maintain | Overweight | $394.00 |
| 2026-05-01 | Canaccord Genuity | maintain | Buy | $400.00 |
| 2026-05-01 | JP Morgan | maintain | Overweight | $400.00 |
| 2026-05-01 | Evercore ISI Group | maintain | Outperform | $355.00 |
| 2026-05-01 | Wells Fargo | maintain | Overweight | $418.00 |
| 2026-05-01 | Needham | maintain | Buy | $418.00 |
30-day activity: 1 upgrade (the initiation), 0 downgrades. EPS revisions show a mixed but slightly positive trend: current fiscal year EPS had 2 upward revisions and 1 downward in the last 30 days, while next fiscal year had 1 up and 2 down. Estimates are broadly stable.
Firm Track Record: BMO Capital
BMO Capital accuracy: 53% on 1842 calls | avg return: 2.3%
Industry benchmark: mean 51% ± 11%. Top tier: ≥61% (mean + 1σ). Based on 15 firms with ≥5 scored calls.
| Firm | Accuracy | Calls | Avg Return | vs Average |
|---|---|---|---|---|
| Piper Sandler | 100% | 3/3 | 4.8% | top tier |
| Roth MKM | 100% | 2/2 | 0.9% | top tier |
| UBS | 100% | 3/3 | 6.2% | top tier |
| Baird | 100% | 2/2 | 4.7% | top tier |
| BTIG | 89% | 8/9 | 4.6% | top tier |
| JMP Securities | 67% | 2/3 | 0% | top tier |
| Stifel | 67% | 2/3 | 2% | top tier |
| Truist Securities | 64% | 7/11 | 1.3% | top tier |
| Evercore ISI Group | 63% | 5/8 | 1.4% | top tier |
| Barclays | 60% | 3/5 | 2.4% | above average |
BMO Capital has a 53% accuracy rate on 1,842 scored calls with an average return of 2.3%. Among firms covering SYK, the top performers are Piper Sandler (100% on 3 calls), UBS (100% on 3, avg return 6.2%), and BTIG (89% on 9, avg return 4.6%). BMO’s accuracy is below those top-tier shops but still solid given its large sample size.
Earnings Estimates
Next earnings: Jul 29, 2026
| Period | EPS Est. | EPS Range | Revenue | Revisions (7d) |
|---|---|---|---|---|
| 0q | $3.49 | $3.36 to $3.61 | $6.6B | ↑0 ↓0 |
| +1q | $3.68 | $3.00 to $3.81 | $6.7B | ↑0 ↓0 |
| 0y | $14.98 | $14.86 to $15.08 | $27.3B | ↑0 ↓0 |
| +1y | $16.72 | $16.43 to $16.96 | $29.6B | ↑0 ↓0 |
Cross-Platform Signals
Insider trades: Robert Fletcher sold a total of ~$1.3M in SYK on May 28, 2026. While the cluster is large, the single-date pattern suggests a planned sale, reducing its bearish signal. Congressional activity: Rep. Ro Khanna bought $15k–$50k in April 2026 (bullish, but small). Institutional flows: Wellington Management added 25.1% ($2.67B position), Assenagon doubled (+263%), and Empowered Funds added 92.4%. Conversely, Norges Bank exited and Walleye Capital reduced 81.2%. Short interest is 76.2% of off-exchange volume, indicating elevated bearish positioning. The analyst signal (bullish) converges with institutional buying but diverges from insider selling and high short interest.
Investment Themes
Documents Analyzed
Report based on filing metadata.
Track record
29 reports on SYK
4 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 6 of 10 went positive at some point.
Filters
- Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
- Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
- Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
- Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
- Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
- Oct 29, 202619d ago 8-K Bearish 6/10 No price data
- Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
- Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
- Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
- Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers